Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040
Sikai Qiu, Jiangying Cai, Zhanpeng Yang, Xinyuan He, Zixuan Xing, Jian Zu, Enrui Xie, Linda Henry, Custis R. Chong, Esther M. John, Ramsey Cheung, Fanpu Ji, Mindie H. Nguyen · 2024
Read Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040 by Sikai Qiu, Jiangying Cai, Zhanpeng Yang, Xinyuan He, Zixuan Xing, Jian Zu, Enrui Xie, Linda Henry, Custis R. Chong, Esther M. John, Ramsey Cheung, Fanpu Ji, Mindie H. Nguyen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11574689.txt.
Description
Qiu and co-authors chart deaths from liver cancer in the United States and project them to 2040, in a 2024 study. Using national death records from 2006 to 2022, the team counted 188,280 deaths from hepatocellular carcinoma in adults. Rates were split by cause of liver disease, age, sex, and race and ethnicity. Trend breaks were found with joinpoint methods, and two forecasting models projected future rates.
Most deaths were in men, about 77 percent. The yearly rise in death rates slowed from 4.1 percent in the late 2000s to 1.8 percent afterward. Causes ranged from alcohol and hepatitis viruses to fatty liver disease. Projections to 2040 give planners a view of where the burden heads, and which groups will carry it.
Catalog record
| CREATOR | Sikai Qiu, Jiangying Cai, Zhanpeng Yang, Xinyuan He, Zixuan Xing, Jian Zu, Enrui Xie, Linda Henry, Custis R. Chong, Esther M. John, Ramsey Cheung, Fanpu Ji, Mindie H. Nguyen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |